Showing 1 - 3 of 3 Viral Infections
A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects

Status: Open Not Enrolling

Investigator: Howard Huang

Study Coordinator: Joshua Henkelman

Phone: 303.579.0171

This is a multi-center, randomized, placebo vs investigational drug - Phase III study to investigate the effectiveness and safety of DAS181 for the treatment of immunocompromised subjects diagnosed with lower respiratory tract infection (LRTI) d ... Read more >

Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Shionogi Protease Inhibitor

Status: Enrolling

Investigator: Eleftherios Mylonakis

Study Coordinator: Diana Avila

Phone: 786.718.8946

Brief Summary: Treatments are needed to improve outcomes among patients hospitalized for COVID-19, including direct-acting antiviral (DAA) agents to mitigate the pathology driven by ongoing viral replication. This trial will evaluate S-217622, ... Read more >

The COVID-19 and Cancer Consortium CCC19 Registry

Status: Open Not Enrolling

Investigator: Jun Zhang

Study Coordinator:

Phone:

Cancer patients have an almost unique risk profile in this pandemic. Many patients, especially those actively on treatment, have high levels of contact with the healthcare system. Many if not all cancer patients are immunocompromised, through th ... Read more >